首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1336762

全球近距離放射治療市場 - 2023-2030

Global Brachytherapy Market - 2023-2030

出版日期: 2023年08月22日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球近距離放射治療市場在 2022 年達到 8 億美元，預計到 2030 年將達到 15 億美元，2023-2030 年預測期間年複合成長率為 8.1%。

近距離放射治療使用密封在種子、顆粒、線或膠囊內的放射性材料，通過針或導管植入體內。該源發出的輻射會損害附近癌細胞的 DNA。近距離放射治療最常用於治療前列腺癌。

它還可用於婦科癌症，如宮頸癌和子宮內膜癌以及乳腺癌。近距離放射治療還可用於其他癌症，包括肺癌、直腸癌、眼癌和皮膚癌。此外，癌症患病率的增加可以擴大近距離放射治療市場規模。

由於美國和加拿大等國家技術進步的大幅提升，北美地區的市場需求增加。 Perspective Therapeutics、Theragenics、Eckert & Ziegler、Civco Medical Solutions 等重要參與者正在市場上積極營運。

動力學

前列腺癌發病率不斷上升可促進市場成長

前列腺癌發病率的增加可以促進市場的成長。例如，據美國癌症協會估計，2023 年美國將新增約 288,300 例前列腺癌病例，並估計約 34,700 人死於前列腺癌。

老年男性和非西班牙裔黑人男性更容易患前列腺癌。每 10 例中約有 6 例是在 65 歲或以上的男性中確診的，在 40 歲以下的男性中很少見。男性首次診斷時的平均年齡約為 66 歲。近距離放射治療程序用於將放射性粒子（顆粒）植入前列腺以殺死前列腺癌細胞。

種子可能會發出大量或少量的輻射。許多前列腺癌患者需要近距離放射治療。因此，上述因素表明前列腺癌的增加可以促進市場成長。

乳腺癌病例數的增加可以促進市場成長

乳腺癌病例數的增加可以加速市場的成長。例如，根據CDC的數據，在美國，每年診斷出的乳腺癌病例約為264,000例女性，約2,400例男性。美國每年約有 42,000 名女性和 500 名男性死於乳腺癌。黑人女性乳腺癌死亡率高於白人女性。

對乳腺癌患者進行間質近距離放射治療。將幾根稱為導管的小空心管插入必須切除的癌症部位周圍的乳房中，並保留幾天。每天將放射性顆粒插入導管一小段時間，然後取出。因此，上述因素表明市場成長速度加快。

與治療相關的副作用可能會降低市場成長

近距離放射治療的副作用包括放射治療部位腫脹、瘀傷、出血或疼痛和不適。用於婦科癌症或前列腺癌的近距離放射治療可能會導致短期泌尿系統症狀，包括尿失禁或排尿疼痛。

這些癌症的近距離放射治療還會導致腹瀉、便秘和直腸出血。前列腺近距離放射治療有時會導致勃起功能障礙。上述因素可能會抑制市場的成長。

Overview

The Global Brachytherapy Market reachedUS$ 0.8 Billion in 2022 and is expected to reach US$ 1.5 Billion by 2030, growing with a CAGR of 8.1%during the forecast period 2023-2030.

Brachytherapy treatment uses radioactive material sealed inside a seed, pellet, wire, or capsule implanted in the body using a needle or catheter. The radiation given off by this source damages the DNA of nearby cancer cells. Brachytherapy is most commonly used to treat prostate cancer.

It also can be used for gynecologic cancers such as cervical cancer and uterine (endometrial) cancer, as well as breast cancer. Brachytherapy can also be utilized in others cancers including lung cancer, rectal cancer, eye cancer, and skin cancer. Furthermore, the increase in the prevalence of cancer can elevate the brachytherapy market size.

Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market experience increased demand from North American regions. Significantkey players like Perspective Therapeutics, Theragenics, Eckert & Ziegler, Civco Medical Solutions, and others are actively operating in the market.

Dynamics

The Growing Incidence of Prostate Cancer can Elevate the Market Growth

The increase in the incidence of prostate cancer can elevate the growth of the market. For instance, according to the American Cancer Society about 288,300 new cases of prostate cancer are estimated in the United States in 2023 and around 34,700 deaths are estimated from prostate cancer.

Prostate cancer is more likely to develop in older men and in non-hispanic black men. About 6 cases in 10 are diagnosed in men 65 or older, and it is rare in men under 40. The average age of men when they are first diagnosed is about 66 years. Brachytherapy procedure is used to implant radioactive seeds (pellets) into the prostate gland to kill prostate cancer cells.

The seeds may give off high or low amounts of radiation. Numerous patients with prostate cancer require brachytherapy. Thus, above mentioned factors demonstrate that an increase in prostate cancer can elevate market growth.

Rise in the Number of Breast Cancer Cases can Boost the Market Growth

An increase in the number of breast cancer cases can accelerate the growth of the market.For instance, according to CDC, each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. About 42,000 women and 500 men in the U.S. die each year from breast cancer. Black women have a higher rate of death from breast cancer than white women.

Interstitial brachytherapy is performed on breast cancer patients. Several small, hollow tubes called catheters are inserted into the breast around the area at the site of the cancer that has to be removed and are left in place for several days. Radioactive pellets are inserted into the catheters for short periods of time each day and then removed. Thus, these aforementioned factors shows the rise in the market growth.

Side Effects Associated with the Treatment can Decline the Market Growth

Side effects of brachytherapy can include swelling, bruising, bleeding, or pain and discomfort at the spot where the radiation was delivered. Brachytherapy used for gynecologic or prostate cancer can lead to short-term urinary symptoms, including incontinence or pain in urination.

Brachytherapy for these cancers can also lead to diarrhea, constipation, and rectal bleeding. Prostate brachytherapy can occasionally cause erectile dysfunction. These above mentioned factors may restrain the market growth.

Segment Analysis

The global brachytherapy market is segmented based on type, indication type, end-user and region.

High Dose Rate Brachytherapy SegmentAccounted for Approximately 39.6% of the Brachytherapy Market Share

High dose rate brachytherapy segment is expected to hold a significant position in the brachytherapy market share. In high dose-rate brachytherapy, the tumour is exposed to a high dosage of radiation but the surrounding organs are greatly spared. Radiation that is administered at a high dose-rate or at a high dose per fraction is known to be particularly sensitive to prostate cancer.

Lower toxicity than with low dosage-rate implants is achieved through quick administration and good dose conformity. Several researches have suggested that the high or intermediate risk patients who are suitable should be provided with high dose rate brachytherapy (HDR) in combination with external beam radiotherapy since it has a greater rate of cancer control than external beam alone.

A single 15 Gy HDR in conjunction with 40-50 Gy external beam radiation yields a disease-free survival rate of over 90% for moderate risk and 80% for high risk, despite the fact that different doses and fractionations have been employed. Thus, the rising research studies by the researchers are expected to raise the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 42.1% of the Market Share in 2022.

North America is expected to hold a significant position in the brachytherapy market share. The increase in technological advancements in healthcare and the agreements by the companies can elevate the growth of the market in this region. For instance, on July 23, 2021, Elekta (EKTA-B.ST) announced that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron brachytherapy afterloader systems, including service agreements.

The cancer treatment devices will allow GenesisCare to continue to invest in the latest world-class technology while providing access to high-quality care to their patients throughout their U.S. centers. GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide, and Elekta is delighted to play a vital partnering role in achieving this mission. Thus, an increase in the strategic initiatives by the key players can elevate the growth of the market.

Competitive Landscape

The major global players in the brachytherapy market include Perspective Therapeutics, Theragenics, Eckert & Ziegler, Civco Medical Solutions, Mirion Technologies, Elekta AB, IsoAid, Varian Medical Systems, Inc., Prowess Inc., RaySearch Laboratories among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the brachytherapy market, posing unprecedented challenges to many countries. The delay in the diagnosis of cancers and also the delay in the treatment procedures have created a negative impact on the growth of the market. The reduction in the advancements and investments by the key companies has created a significant decline in the growth of the market. Thus, COVID-19 has created a negative impact on the growth of the market.

By Type

High-Dose Brachytherapy
Low-Dose Brachytherapy

By Indication Type

Prostate Cancer
Gynecological Cancer
Breast Cancer
Others

By End-User

Hospitals
Ambulatory Surgery Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On July 14, 2023, BEBIG Medical, a global provider of high-quality radiation therapy products, is pleased to announce its successful bid in the Ministry of Health (MOH) tender in Indonesia. BEBIG Medical has been awarded contracts to supply 6 units of HDR (high dose rate) brachytherapy equipment to hospitals across the country. This achievement highlights BEBIG Medical's commitment to delivering cutting-edge medical technology to support cancer treatment in Indonesia.
On April 20, 2023, Elekta announced that an estimated two million brachytherapy treatments have been delivered by healthcare providers using Flexitron high dose rate (HDR) afterloader. One site that has contributed to this treatment milestone is Amsterdam University Medical Centers (Amsterdam UMC) in the Netherlands, which acquired the 1,000th Flexitron recently manufactured at Elekta's facility in Veenendaal.
On January 5, 2023, C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. has received U.S. Food and Drug Administration (FDA) clearance for the use of C4 Imaging's Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray's Cesium-131, brachytherapy seeds.

Why Purchase the Report?

To visualize the global brachytherapy market segmentation based on type, indication type, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of brachytherapy market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The global brachytherapy market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Indication Type
3.3. Snippet by End-user
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The Growing Incidence of Prostate Cancer
  - 4.1.1.2. Rise in the Number of Breast Cancer Cases
- 4.1.2. Restraints
  - 4.1.2.1. Side Effects Associated with the Treatment
- 4.1.3. Opportunity
  - 4.1.3.1. Advancements in Healthcare
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. High-Dose Brachytherapy
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Low-Dose Brachytherapy

8. By Indication Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 8.1.2. Market Attractiveness Index, By Indication Type
8.2. Prostate Cancer
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gynecological Cancer
8.4. Breast Cancer
8.5. Others

9. By End-user

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Perspective Therapeutics
- 12.1.1. Company Overview
- 12.1.2. ProductPortfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Theragenics
12.3. Eckert & Ziegler
12.4. Civco Medical Solutions
12.5. Mirion Technologies
12.6. Elekta AB
12.7. IsoAid
12.8. Varian Medical Systems, Inc.
12.9. Prowess Inc.
12.10. RaySearch Laboratories

LIST NOT EXHAUSTIVE